These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 20038679)
1. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. Geserick P; Hupe M; Moulin M; Wong WW; Feoktistova M; Kellert B; Gollnick H; Silke J; Leverkus M J Cell Biol; 2009 Dec; 187(7):1037-54. PubMed ID: 20038679 [TBL] [Abstract][Full Text] [Related]
2. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Feoktistova M; Geserick P; Kellert B; Dimitrova DP; Langlais C; Hupe M; Cain K; MacFarlane M; Häcker G; Leverkus M Mol Cell; 2011 Aug; 43(3):449-63. PubMed ID: 21737330 [TBL] [Abstract][Full Text] [Related]
3. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681 [TBL] [Abstract][Full Text] [Related]
4. Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complex. Morgan MJ; Kim YS; Liu ZG J Immunol; 2009 Sep; 183(5):3278-84. PubMed ID: 19641134 [TBL] [Abstract][Full Text] [Related]
5. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. de Almagro MC; Goncharov T; Newton K; Vucic D Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062 [TBL] [Abstract][Full Text] [Related]
6. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival. Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820 [TBL] [Abstract][Full Text] [Related]
7. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex. Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322 [TBL] [Abstract][Full Text] [Related]
8. Regulation of CD95/Fas signaling at the DISC. Lavrik IN; Krammer PH Cell Death Differ; 2012 Jan; 19(1):36-41. PubMed ID: 22075988 [TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221 [TBL] [Abstract][Full Text] [Related]
10. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. Strauss G; Knape I; Melzner I; Debatin KM J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203 [TBL] [Abstract][Full Text] [Related]
11. Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Nguyen XH; Lang PA; Lang KS; Adam D; Fattakhova G; Föger N; Kamal MA; Prilla P; Mathieu S; Wagner C; Mak T; Chan AC; Lee KH Blood; 2011 Jul; 118(3):598-608. PubMed ID: 21613257 [TBL] [Abstract][Full Text] [Related]
12. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways. Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254 [TBL] [Abstract][Full Text] [Related]
13. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8. Ikner A; Ashkenazi A J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013 [TBL] [Abstract][Full Text] [Related]
14. Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of protein kinase Cepsilon. Dash PR; McCormick J; Thomson MJ; Johnstone AP; Cartwright JE; Whitley GS Exp Cell Res; 2007 Oct; 313(16):3421-31. PubMed ID: 17761163 [TBL] [Abstract][Full Text] [Related]
15. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Tenev T; Bianchi K; Darding M; Broemer M; Langlais C; Wallberg F; Zachariou A; Lopez J; MacFarlane M; Cain K; Meier P Mol Cell; 2011 Aug; 43(3):432-48. PubMed ID: 21737329 [TBL] [Abstract][Full Text] [Related]
16. Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network. Pietkiewicz S; Eils R; Krammer PH; Giese N; Lavrik IN Exp Cell Res; 2015 Nov; 339(1):1-9. PubMed ID: 26453936 [TBL] [Abstract][Full Text] [Related]
17. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Vanlangenakker N; Vanden Berghe T; Bogaert P; Laukens B; Zobel K; Deshayes K; Vucic D; Fulda S; Vandenabeele P; Bertrand MJ Cell Death Differ; 2011 Apr; 18(4):656-65. PubMed ID: 21052097 [TBL] [Abstract][Full Text] [Related]
18. RIP-in CD95-induced cell death: The control of alternative death receptors pathways by cIAPs. Geserick P; Hupe M; Moulin M; Leverkus M Cell Cycle; 2010 Jul; 9(14):2689-91. PubMed ID: 20581447 [No Abstract] [Full Text] [Related]
19. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. Fulda S; Strauss G; Meyer E; Debatin KM Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716 [TBL] [Abstract][Full Text] [Related]
20. The C-terminal domain of the long form of cellular FLICE-inhibitory protein (c-FLIPL) inhibits the interaction of the caspase 8 prodomain with the receptor-interacting protein 1 (RIP1) death domain and regulates caspase 8-dependent nuclear factor κB (NF-κB) activation. Matsuda I; Matsuo K; Matsushita Y; Haruna Y; Niwa M; Kataoka T J Biol Chem; 2014 Feb; 289(7):3876-87. PubMed ID: 24398693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]